Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (352)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
2023
268
5.610
Why?
Down Syndrome
6
2023
340
1.620
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2022
1381
1.530
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
9
2023
66
1.460
Why?
Asparaginase
8
2020
26
0.970
Why?
Burkitt Lymphoma
2
2020
53
0.850
Why?
Child
65
2023
18921
0.780
Why?
Consolidation Chemotherapy
2
2019
9
0.760
Why?
Leukemia, Myeloid, Acute
5
2022
542
0.720
Why?
Child, Preschool
45
2023
9340
0.670
Why?
Leukemia
4
2021
208
0.630
Why?
Mercaptopurine
5
2017
15
0.590
Why?
Disease-Free Survival
11
2023
642
0.580
Why?
Oncogene Proteins, Fusion
5
2021
177
0.560
Why?
Neoplasm Recurrence, Local
4
2023
888
0.550
Why?
Antineoplastic Agents
7
2019
1946
0.540
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
92
0.520
Why?
Preleukemia
1
2015
2
0.520
Why?
Molecular Targeted Therapy
3
2021
353
0.500
Why?
Drug Hypersensitivity
3
2017
86
0.500
Why?
Leukemia, Monocytic, Acute
1
2014
4
0.490
Why?
Sarcoma, Myeloid
1
2014
4
0.490
Why?
Prognosis
13
2021
3407
0.470
Why?
Infant
32
2023
8154
0.470
Why?
Neoplasm, Residual
7
2023
111
0.470
Why?
Bone Marrow Transplantation
1
2014
244
0.440
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
16
0.430
Why?
Adolescent
37
2023
18254
0.430
Why?
Acute Kidney Injury
1
2019
699
0.420
Why?
Erwinia
2
2020
3
0.410
Why?
Tumor Suppressor Proteins
3
1999
286
0.410
Why?
Chromosome Aberrations
2
2022
135
0.400
Why?
Recurrence
9
2023
970
0.390
Why?
Hematopoietic Stem Cell Transplantation
2
2019
536
0.390
Why?
Neutropenia
2
2022
129
0.390
Why?
Humans
77
2023
117617
0.390
Why?
Male
53
2023
56907
0.390
Why?
Stem Cell Transplantation
3
2019
151
0.380
Why?
Rhabdomyosarcoma
1
2011
54
0.370
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
93
0.370
Why?
Sarcoma, Ewing
1
2011
64
0.360
Why?
Cell Cycle Proteins
3
1999
565
0.360
Why?
Carrier Proteins
3
1999
723
0.360
Why?
Ploidies
2
2019
17
0.350
Why?
Catheter-Related Infections
2
2022
59
0.340
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
30
0.330
Why?
Genes, Tumor Suppressor
2
1999
76
0.330
Why?
Cyclophosphamide
4
2019
221
0.330
Why?
Catheterization, Central Venous
2
2022
90
0.320
Why?
Female
50
2023
60917
0.310
Why?
Philadelphia Chromosome
2
2018
15
0.300
Why?
Survival Rate
7
2021
1682
0.290
Why?
Medication Adherence
3
2017
556
0.280
Why?
Vincristine
4
2021
99
0.280
Why?
Gene Deletion
2
1998
356
0.280
Why?
Trisomy
2
2021
65
0.270
Why?
Neoplasm Proteins
2
2018
395
0.270
Why?
Etoposide
2
2019
149
0.270
Why?
Antimetabolites, Antineoplastic
2
2017
83
0.270
Why?
Treatment Outcome
12
2023
9296
0.250
Why?
Young Adult
14
2023
10721
0.250
Why?
Anxiety
3
2016
848
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
57
0.240
Why?
Medical Oncology
4
2022
231
0.220
Why?
Gene Rearrangement
3
2019
141
0.210
Why?
Polyethylene Glycols
5
2020
574
0.210
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
59
0.210
Why?
Induction Chemotherapy
2
2019
58
0.210
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
2
0.210
Why?
Adult
22
2023
31154
0.210
Why?
Central Venous Catheters
1
2022
41
0.200
Why?
Doxorubicin
2
2022
300
0.200
Why?
Lymphoma
1
2023
178
0.200
Why?
Program Evaluation
2
2017
828
0.200
Why?
Prednisone
2
2019
233
0.200
Why?
Lung Neoplasms
1
2014
2209
0.190
Why?
Translocation, Genetic
2
2013
88
0.190
Why?
Polymorphism, Single Nucleotide
3
2017
2043
0.180
Why?
Risk Factors
11
2022
8918
0.180
Why?
Maintenance Chemotherapy
2
2017
22
0.180
Why?
Bacterial Infections
1
2022
225
0.180
Why?
Diploidy
1
2019
11
0.180
Why?
Immunocompromised Host
1
2021
197
0.180
Why?
Genes, p16
1
1999
18
0.170
Why?
Prospective Studies
9
2022
6426
0.170
Why?
Hyperglycemia
1
2023
308
0.170
Why?
PAX5 Transcription Factor
1
2019
12
0.170
Why?
Antibodies, Bispecific
1
2019
34
0.170
Why?
Myelodysplastic Syndromes
1
2020
119
0.170
Why?
Chromosomes, Human, Pair 19
1
1998
24
0.160
Why?
Chromosomes, Human, Pair 17
1
1998
61
0.160
Why?
Rituximab
1
2019
153
0.160
Why?
Mutagenesis
1
1999
176
0.160
Why?
Chromosomes, Human, Pair 1
1
1998
71
0.160
Why?
Patient Safety
1
2021
279
0.160
Why?
Quality of Life
2
2021
2381
0.150
Why?
Prostate-Specific Antigen
2
2009
154
0.150
Why?
Substance Withdrawal Syndrome
1
2020
156
0.150
Why?
Proto-Oncogenes
1
1997
27
0.150
Why?
Family Relations
2
2016
84
0.150
Why?
Oncologists
1
2017
31
0.150
Why?
Thionucleotides
1
2017
34
0.150
Why?
Apyrase
1
2017
13
0.150
Why?
Thioguanine
1
2017
20
0.150
Why?
Follow-Up Studies
6
2021
4528
0.150
Why?
Blast Crisis
1
2016
19
0.140
Why?
Depression
2
2016
1135
0.140
Why?
Retrospective Studies
9
2023
12906
0.140
Why?
Carboxypeptidases A
1
2016
2
0.140
Why?
Genomics
2
2022
657
0.140
Why?
Pediatricians
1
2017
120
0.140
Why?
Sepsis
1
2022
528
0.140
Why?
Mentors
2
2017
165
0.130
Why?
Mentoring
1
2017
102
0.130
Why?
Osteonecrosis
1
2015
19
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
279
0.130
Why?
Longitudinal Studies
7
2016
2487
0.130
Why?
Nausea
1
2016
106
0.130
Why?
Adrenal Cortex Hormones
1
2019
512
0.130
Why?
Central Nervous System Neoplasms
1
2017
128
0.130
Why?
Pancreatitis
1
2016
103
0.130
Why?
Mutation
4
2022
3428
0.130
Why?
Dexamethasone
4
2021
314
0.130
Why?
Fusion Proteins, bcr-abl
2
2016
60
0.120
Why?
Bacteremia
1
2016
159
0.120
Why?
Monitoring, Physiologic
1
2017
262
0.120
Why?
High-Throughput Nucleotide Sequencing
1
2017
455
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.120
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
64
0.120
Why?
Antigens, CD
1
2017
451
0.120
Why?
Flow Cytometry
1
2018
1066
0.120
Why?
Cross Infection
1
2016
204
0.120
Why?
Repressor Proteins
1
1997
377
0.120
Why?
Histone-Lysine N-Methyltransferase
2
2010
99
0.120
Why?
Immunotherapy
1
2018
492
0.120
Why?
Pediatrics
3
2021
976
0.120
Why?
DNA-Binding Proteins
2
1998
1340
0.120
Why?
Life Change Events
1
2014
129
0.120
Why?
Chromosomes, Human, Pair 21
1
2013
32
0.110
Why?
Quality Improvement
1
2021
964
0.110
Why?
Venous Thromboembolism
1
2017
236
0.110
Why?
Self Report
1
2017
702
0.110
Why?
Transcription Factors
2
1998
1558
0.110
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.110
Why?
Karyotyping
3
2019
102
0.110
Why?
Myeloproliferative Disorders
1
2012
25
0.110
Why?
Contraindications
1
2012
85
0.100
Why?
Arabinonucleosides
1
2011
8
0.100
Why?
Adenine Nucleotides
1
2011
20
0.100
Why?
Antibodies, Monoclonal
1
2018
1275
0.100
Why?
Cohort Studies
5
2021
5057
0.100
Why?
Prostatic Neoplasms
2
2009
939
0.100
Why?
Chromosomes, Human, Pair 4
1
2010
28
0.090
Why?
Chromosomes, Human, Pair 10
1
2010
18
0.090
Why?
T-Lymphocytes
1
2018
1770
0.090
Why?
Pain
1
2016
727
0.090
Why?
Parents
2
2016
1217
0.090
Why?
Multivariate Analysis
4
2015
1463
0.090
Why?
Age Factors
8
2019
2961
0.080
Why?
Neoplasm Metastasis
1
2011
536
0.080
Why?
Prostatectomy
1
2009
99
0.080
Why?
Bloom Syndrome
1
1988
1
0.080
Why?
Juxtaglomerular Apparatus
1
2007
1
0.080
Why?
Gene Expression Regulation, Leukemic
2
2016
49
0.080
Why?
Polymerase Chain Reaction
1
2010
1005
0.070
Why?
Blood Coagulation
1
2008
203
0.070
Why?
Stress, Psychological
1
2014
958
0.070
Why?
Drug Administration Schedule
2
2017
727
0.070
Why?
Methotrexate
2
2017
228
0.060
Why?
Remission Induction
2
2019
245
0.060
Why?
Drug Monitoring
2
2017
185
0.060
Why?
Acute Disease
2
2019
915
0.060
Why?
Personal Satisfaction
2
2017
183
0.060
Why?
Administration, Oral
2
2017
744
0.060
Why?
Kidney Neoplasms
1
2007
333
0.060
Why?
Genetic Variation
1
1988
902
0.060
Why?
Disease Progression
2
2021
2470
0.050
Why?
Randomized Controlled Trials as Topic
2
2020
1235
0.050
Why?
Risk
5
2023
842
0.050
Why?
Transcriptome
2
2019
752
0.050
Why?
Incidence
2
2019
2387
0.050
Why?
Proto-Oncogene Proteins c-cbl
1
2022
12
0.050
Why?
Exome
1
2022
209
0.050
Why?
Drug Therapy
1
2021
76
0.050
Why?
Diarrhea
2
1999
179
0.050
Why?
Risk Assessment
3
2017
3032
0.050
Why?
Bone Marrow
1
2022
250
0.050
Why?
Surveys and Questionnaires
3
2017
4689
0.050
Why?
Endocrine Glands
1
1979
16
0.040
Why?
Blood Cell Count
1
1999
52
0.040
Why?
Viral Load
1
2021
406
0.040
Why?
Chromosomes, Human
1
2019
40
0.040
Why?
Azacitidine
1
2020
128
0.040
Why?
Loss of Heterozygosity
1
1999
40
0.040
Why?
Cytogenetic Analysis
1
2019
29
0.040
Why?
Genome-Wide Association Study
2
2016
1314
0.040
Why?
Interviews as Topic
1
2021
591
0.040
Why?
Mosaicism
1
2019
64
0.040
Why?
Infant, Newborn
4
2019
5209
0.040
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
173
0.040
Why?
United States
4
2021
12427
0.040
Why?
Overweight
1
2023
488
0.040
Why?
Disinfectants
1
1999
33
0.040
Why?
Sequence Deletion
1
1999
168
0.040
Why?
Chromosomes
1
2019
85
0.040
Why?
National Cancer Institute (U.S.)
1
2018
41
0.040
Why?
Hypertension
1
2007
1187
0.040
Why?
Escherichia coli O157
1
1998
30
0.040
Why?
Methylation
1
1998
204
0.040
Why?
Feasibility Studies
1
2021
753
0.040
Why?
Community Participation
1
1999
120
0.040
Why?
Family
1
2021
578
0.040
Why?
Genetic Predisposition to Disease
2
2017
2232
0.040
Why?
Glucose
1
2023
931
0.040
Why?
Erythrocyte Count
1
2017
19
0.040
Why?
Public Health Surveillance
1
2017
60
0.040
Why?
Escherichia coli Infections
1
1998
102
0.040
Why?
Biopsy
1
2021
1060
0.040
Why?
Food-Drug Interactions
1
2017
6
0.040
Why?
Leucovorin
1
2017
42
0.040
Why?
Injections, Intramuscular
1
2017
118
0.040
Why?
Proto-Oncogene Proteins c-ets
1
1997
51
0.040
Why?
Career Mobility
1
2017
64
0.040
Why?
Water Purification
1
1999
131
0.040
Why?
Dairy Products
1
2017
31
0.040
Why?
Cranial Irradiation
1
2017
69
0.040
Why?
Middle Aged
10
2019
27300
0.040
Why?
Sulfonamides
1
2020
454
0.040
Why?
Cerebrospinal Fluid
1
2017
92
0.040
Why?
MEF2 Transcription Factors
1
2016
57
0.040
Why?
Infusions, Intravenous
1
2017
375
0.040
Why?
Methyltransferases
1
2017
61
0.040
Why?
Leukocyte Count
1
2017
297
0.040
Why?
Qualitative Research
1
2021
961
0.040
Why?
NIH 3T3 Cells
1
2016
138
0.040
Why?
Luciferases
1
2016
138
0.040
Why?
Breast Neoplasms
5
1979
1951
0.030
Why?
Methyl Ethers
1
1996
8
0.030
Why?
Anesthetics, Inhalation
1
1996
13
0.030
Why?
Ethers
1
1996
17
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
9
0.030
Why?
Fluorides
1
1996
47
0.030
Why?
Health Education
1
1999
314
0.030
Why?
Cytarabine
1
2016
53
0.030
Why?
Severity of Illness Index
2
2017
2643
0.030
Why?
Alternative Splicing
1
2017
189
0.030
Why?
Genotype
3
2017
1858
0.030
Why?
Intensive Care Units, Pediatric
1
2016
158
0.030
Why?
Disease Management
1
2019
560
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
200
0.030
Why?
Homeodomain Proteins
1
1998
466
0.030
Why?
Aged
9
2019
19482
0.030
Why?
HEK293 Cells
1
2017
626
0.030
Why?
DNA Methylation
1
1999
509
0.030
Why?
Biomarkers, Tumor
1
2021
1058
0.030
Why?
Promoter Regions, Genetic
1
1999
1141
0.030
Why?
Sequence Analysis, RNA
1
2016
407
0.030
Why?
Algorithms
1
2021
1519
0.030
Why?
Blood Glucose
1
2023
1924
0.030
Why?
Income
1
2014
172
0.030
Why?
Marriage
1
2014
108
0.030
Why?
Behavior
1
2014
94
0.030
Why?
Psychomotor Agitation
1
2014
70
0.030
Why?
Demography
1
2014
273
0.030
Why?
Base Sequence
1
2016
2125
0.030
Why?
Case-Control Studies
2
2016
3121
0.030
Why?
Clinical Trials as Topic
1
2017
959
0.030
Why?
In Situ Hybridization, Fluorescence
1
2013
309
0.030
Why?
Odds Ratio
1
2015
988
0.030
Why?
Aggression
1
2014
182
0.030
Why?
Nucleoside Transport Proteins
1
2011
4
0.030
Why?
Erythrocytes
1
2017
618
0.030
Why?
Time Factors
2
2015
6267
0.030
Why?
Regression Analysis
1
2014
979
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
69
0.020
Why?
Escherichia coli
1
2015
749
0.020
Why?
Mice
2
2019
15311
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
180
0.020
Why?
Bacteria
1
2016
753
0.020
Why?
Survival Analysis
1
2013
1246
0.020
Why?
Logistic Models
1
2015
1887
0.020
Why?
Obesity
1
2023
2660
0.020
Why?
Prevalence
1
2016
2307
0.020
Why?
Mice, Inbred C57BL
1
2019
4835
0.020
Why?
Kaplan-Meier Estimate
1
2011
831
0.020
Why?
Emotions
1
2014
488
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Genetic Complementation Test
1
1988
62
0.020
Why?
Cell Fusion
1
1988
50
0.020
Why?
Protein C
1
2008
42
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
76
0.020
Why?
Antithrombins
1
2008
50
0.020
Why?
Water Microbiology
2
1999
77
0.020
Why?
Fibrinogen
1
2008
150
0.020
Why?
Biomarkers
1
2017
3562
0.020
Why?
Genetic Markers
1
1988
338
0.020
Why?
Renin-Angiotensin System
1
2007
82
0.020
Why?
Biopsy, Needle
1
2007
184
0.020
Why?
Transplantation, Homologous
1
2008
408
0.020
Why?
Rare Diseases
1
2007
91
0.020
Why?
Blood Pressure Determination
1
2007
133
0.020
Why?
Nephrectomy
1
2007
160
0.020
Why?
Animals
2
2019
32782
0.020
Why?
RNA, Messenger
1
2011
2629
0.010
Why?
Immunohistochemistry
1
2007
1660
0.010
Why?
Cell Line
1
1988
2674
0.010
Why?
Estriol
1
1979
5
0.010
Why?
Menstruation
1
1979
35
0.010
Why?
Estrone
1
1979
35
0.010
Why?
Prolactin
1
1979
94
0.010
Why?
Bolivia
1
1999
60
0.010
Why?
Luteinizing Hormone
1
1979
173
0.010
Why?
Follicle Stimulating Hormone
1
1979
216
0.010
Why?
Restaurants
1
1998
17
0.010
Why?
Food Handling
1
1998
48
0.010
Why?
Swimming
1
1998
45
0.010
Why?
Progesterone
1
1979
240
0.010
Why?
Disease Transmission, Infectious
1
1998
56
0.010
Why?
Water Supply
1
1998
71
0.010
Why?
Meat
1
1998
89
0.010
Why?
Estradiol
1
1979
467
0.010
Why?
Halothane
1
1996
5
0.010
Why?
Analysis of Variance
1
1999
1248
0.010
Why?
Population Surveillance
1
1999
411
0.010
Why?
Feces
1
1998
390
0.010
Why?
Ovarian Neoplasms
1
1978
416
0.010
Why?
Pedigree
3
1978
475
0.010
Why?
Kidney
1
1996
1343
0.000
Why?
Aged, 80 and over
1
1999
6514
0.000
Why?
Nebraska
2
1976
9
0.000
Why?
New York
2
1976
113
0.000
Why?
Genes
1
1978
222
0.000
Why?
Genetic Linkage
1
1978
311
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
57
0.000
Why?
Pheochromocytoma
1
1976
54
0.000
Why?
Klinefelter Syndrome
1
1976
53
0.000
Why?
Syndrome
1
1976
339
0.000
Why?
Pregnancy
2
1978
5710
0.000
Why?
Statistics as Topic
1
1976
301
0.000
Why?
HLA Antigens
1
1976
223
0.000
Why?
Skin Diseases
1
1976
125
0.000
Why?
Sarcoma
1
1976
136
0.000
Why?
Abnormalities, Multiple
1
1976
178
0.000
Why?
Sex Factors
1
1978
1756
0.000
Why?
Thyroid Neoplasms
1
1976
265
0.000
Why?
Neoplasms
2
1976
2152
0.000
Why?
Melanoma
1
1976
665
0.000
Why?
Registries
1
1976
1784
0.000
Why?
Phenotype
1
1976
2894
0.000
Why?
Brain Neoplasms
1
1976
1016
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)